期刊
BLOOD PURIFICATION
卷 43, 期 1-3, 页码 91-96出版社
KARGER
DOI: 10.1159/000453577
关键词
Statins; Acute kidney injury; Chronic kidney disease; Rhabdomyolysis; Contrast-induced nephropathy; Cardiorenal syndrome; End-stage renal disease
Statins essentially are cholesterol-lowering drugs that are extensively prescribed for primary and secondary prevention of cardiovascular disease. Compelling evidence suggests that the beneficial effects of statins may not only be due to controlling cholesterol levels but also due to a pleiotropic cholesterol-independent anti-inflammatory, antioxidant, endothelial-protective and plaque-stabilizing activity. Along this line, statins may also exert acute and long-term effects on renal function. We present a narrative literature review that summarizes arguments in favour or against the preventive and/or therapeutic use of statins in kidney-related diseases or complications. We also highlight the ongoing controversy regarding statin therapy in chronic and endstage kidney disease. (C) 2016 S. Karger AG, Basel
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据